Stay updated on Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.6.5 indicates a software version update for the page. The study details and content appear unchanged.
    Difference
    0.1%
    Check dated 2026-08-09T08:53:50.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 in the page footer, indicating a small site revision rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-07-25T17:59:02.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor version update to the page rendering. No study data or details appear to have been modified.
    Difference
    0.1%
    Check dated 2026-07-04T13:19:41.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, signaling a newer version of the page. This change is a metadata update and does not indicate a substantive modification to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T05:59:26.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate the study is not enrolling, and new sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added to help users navigate the page. The Interventions header formatting was adjusted (Intervention/Treatment) and the revision label updated to v3.6.0, reflecting UI and version changes.
    Difference
    0.5%
    Check dated 2026-06-13T04:33:00.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    Revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the site’s backend or presentation. This update does not modify study data, text, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-06-05T22:52:51.000Z thumbnail image

Stay in the know with updates to Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.